N/A N=303 Optical Coherence Tomography (OCT) Data Collection Study
Glaucoma
Primary: Primary Endpoints — 97.2; 83.9; 73.9; 336.1 microns
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=48 Topcon 3D OCT-1000 Optical Coherence Tomography System
Retinal Disease · Glaucoma
Primary: Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device — 235.0; 236.1; NA; 236.0 µm
N/A N=70 Low Cost OCT for Point of Care
Optical Coherence Tomography (OCT) of the Retina
Primary: Number of Participants With Acceptable OCT Image Quality — 60 Participants
N/A N=109 Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
Barrett's Esophagus
Primary: Number of Subjects in Which the Entire Distal Esophagus Can be Visualized Using the Balloon Based Optical Coherence Tomography Screening — 109 Participants
N/A N=385 OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Diabetes · Diabetic Macular Edema · Diabetic Retinopathy
Primary: Rates of Retina Care Referral for Patients With Diabetic Macular Edema — 44 Participants
N/A N=218 Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
Uveitis · Iritis · Iridocyclitis
Primary: Macular Thickness Measured With the OCT; in Relation to Age, Sex, Reproductive Factors and the Use of Anti-inflammatory Eye Drops in Health; in Uncomplicated Anterior…
N/A N=10 Study Comparing the P200TE and the P200TxE in Glaucoma Patients
Glaucoma
Primary: Qualitative B-Scan Assessment — 2.78; 2.77; 2.08 Mean score on a scale (0-3)
N/A N=53 OCT Pilot in Esophagus
Barrett Esophagus
Primary: Percentage of Imaged Sites Correctly Categorized as Squamous Mucosa — 93.1 percentage of imaged sites
Phase 4 N=26 The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
Wet Macular Degeneration
Primary: Area of Lesion Measured by Optical Coherence Tomography Angiography (OCTA) Scan. — 1.07 mm^2
N/A N=109 Clinical Study of the Optic Disc Parameters
Normal Healthy Subjects With No Known Ocular Diseases · Glaucomatous Eyes · Eyes With Retinal Diseases
Primary: Optic Disc Measurements (Optic Disc Size) — 0.197; 0.097; 0.201 Mircrons squared
N/A N=33 Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye
Glaucoma
Primary: Lamina Cribrosa (Boundaries of the Retinal Layers) Measurements — 264.3; 273.3; 276.2 micro-ohms
N/A N=12 Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging
Peripheral Artery Disease
Primary: Visualization of Vessel Morphology: Layered Structure — 1.61; 1.49 score on a scale
N/A N=36 In Vivo Assessment of the Tooth-Resin Composite Interface Using Optical Coherence Tomography
Cavity · Cavities of Teeth
Primary: Marginal Staining: World Dental Federation (FDI) Criteria - Baseline — 18; 18; 0; 0 Participants
N/A N=129 Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis
Carotid Stenosis
Primary: Radical Peripapillary Capillaries Vessel Density — 55.95; 57.24 percentage of vessel
N/A N=418 Observational Study of OCT in a Patients Undergoing FFR
Coronary Artery Disease
Primary: Incidence of OCT Peri-procedural Guidance Parameter(s) for Stenting — 0; 6.7; 6.2; 0.2 Percentage of per-subject incidence
N/A N=52 Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)
Age Related Macular Degeneration · Geographic Atrophy
Primary: Difference in mm Squared of Cirrus HD-OCT Automated Measurements of the Illumination Areaa Under the RPE to Expert Manual Measurement of Areas of Hypofluorescence…
Phase 4 N=31 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
Diabetic Macular Edema · Ischemic Maculopathy
Primary: FAZ Area Change — 0.03 mm^2
Phase 4 N=35 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
Glaucoma; Drugs · Normal Tension Glaucoma · Primary Open-angle Glaucoma
Primary: Changes in Vessel Density in Treatment Groups Assessed by OCT Angiography — -0.51; 2.59; -0.96; 0.96 percent change
N/A N=71 Side Branch FFR After Provisional Stenting
Coronary Artery Disease
Primary: Number of Participants With Side Branch Compromise — 7; 9 Participants
N/A N=23 Optical Imaging Measurement of Intravascular Solution Efficacy Trial
Peripheral Artery Disease
Primary: Quality of Images — .702; .872; .10; .743 Clear imaging field (CIF) proportion
N/A N=59 The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy
Rhegmatogenous Retinal Detachment · Toxic Effect of Silicone · Glaucoma Due to Silicon Oil
Primary: Evidence of Retinal Nerve Fibre Layer Thickness Change Measured by Optical Coherence Tomography — 96.23; 87.07; 96.09; 87.93 micrometer
N/A N=57 SDOCT-GMPE Software
Glaucoma
Primary: Retinal Nerve Fiber Layer (RNFL) Thickness Correlation Width Global Bruch's Membrane Opening-minimum Rim Width (BMO-MRW) — 0.70 correlation coefficient
N/A N=22 Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus
Barrett's Esophagus
Primary: Number of Subjects in Which the Targeted Locations Identified Through OFDI Imaging Correlates With the Biopsies. — 22 Participants
N/A N=32 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Age-Related Macular Degeneration · Geographic Atrophy · Diabetic Retinopathy
Primary: Standard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations — 16.16; 12.23 decibels
N/A N=450 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation
Coronary Artery Disease
Primary: Primary Efficacy Endpoint (Powered): Post-PCI Median Minimum Stent Area (MSA) — 5.79; 5.89; 5.49 mm^2
N/A N=170 Agreement and Precision Study of the Nidek Mirante
Glaucoma · Retinal Disease · Corneal Disease
Primary: Agreement of Macular Thickness (μm) Measurement for Nidek Mirante and Optovue RTVue XR Avanti OCT — 10.658; 11.032; 11.415; 19.200 μm
Phase 3 N=91 Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
Neovascular Age Related Macular Degeneration
Primary: Multifocal Electroretinography N1-P1 Amplitude — 3.6; 5.3; 4.9; 4.0 nV/deg^2
N/A N=49 Visualizing Dermal Micropores With OCT
Healthy
Primary: Micropore Depth, Upper Arm — 72.4 micrometer
Phase 4 N=87 A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®
Relapsing Remitting Multiple Sclerosis RRMS
Primary: Change From Baseline to Month 36 in Average Retinal Nerve Fiber Layer Thickness (RNFLT) — -1.5 micrometer
N/A N=5 Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department
Retinal Detachment
Primary: Number of Participants With Retinal Detachment Per Ultrasound Assessment — 5 Participants